The effect of radiolabeled nanostructured lipid carrier systems containing imatinib mesylate on NIH-3T3 and CRL-1739 cells

The aim of current study is to develop new nanostructured lipid carrier systems (NLCSs) containing imatinib mesylate (IMT) and evaluate their targeting efficiency on NIH-3T3 as fibroblast cells and CRL-1739 as gastric adenocarcinoma cells with radiolabeled formulations. Three formulations (F1-IMT, F...

Descripción completa

Detalles Bibliográficos
Autores principales: Gundogdu, Evren Atlihan, Demir, Emine Selin, Ekinci, Meliha, Ozgenc, Emre, Ilem Ozdemir, Derya, Senyigit, Zeynep, Asikoglu, Makbule
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745890/
https://www.ncbi.nlm.nih.gov/pubmed/33263456
http://dx.doi.org/10.1080/10717544.2020.1841337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745890/
https://www.ncbi.nlm.nih.gov/pubmed/33263456
http://dx.doi.org/10.1080/10717544.2020.1841337

Ejemplares similares